INX-315
Product Specifications
CAS Number
2745060-92-6
Target
CDK, Early 2 Factor (E2F)
Related Pathways
Cell Cycle/Checkpoint
Purity
0.9988
Bioactivity
INX-315 is an orally active, selective CDK2 inhibitor that induces cell cycle arrest and senescence in solid tumours, suppresses E2F target gene expression, and exhibits anticancer activity in ccne1-amplified cancers and cdk4/6i-resistant intraductal breast cancer models.
Smiles
O=C1NNC2=CC=3C=NC(=NC3N2C14CCCCC4)NC5=CC=C(C=C5)S(=O)(=O)N
Molecular Formula
C19H21N7O3S
Molecular Weight
427.48
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6442649-01 0.1 mL
UQCRC2 (Ubiquinol Cytochrome C Reductase Core Protein 2, QCR2, UQCR2, MC3DN5) (MaxLight 405)
Sign In for Pricing
View Details MBS6442649-02 5x 0.1 mL
UQCRC2 (Ubiquinol Cytochrome C Reductase Core Protein 2, QCR2, UQCR2, MC3DN5) (MaxLight 405)
Sign In for Pricing
View Details 
DZ41526-APC 200 µL/Vial
Anti-Influenza A virus Cali Antibody, APC Conjugate
Sign In for Pricing
View Details GTR15380008 1 Vial
Lentiviral human COQ5 sgRNA gene knockout kit - Lentiviral human COQ5 sgRNA gene knockout kit (100)
Sign In for Pricing
View Details